TY  - CONF

T1  - Gefitinib (Iressa (TM), ZD1839) enhances the activity of the novel vascular-targeting agent ZD6126 in human colorectal cancer and non-small cell lung cancer (NSCLC) xenograft models.

JO  - CLINICAL CANCER RESEARCH

PY  - 2003/01/01

AU  - Guy SP

AU  - Ashton S

AU  - Hughes G

AU  - Westwood R

AU  - Blakey DC

AU  - Ryan AJ

ED  - 

VL  - 9

IS  - 16

SP  - 6142S

EP  - 6142S

Y2  - 2024/12/26

ER  -